Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder

References

• Hofmann AF. The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy. Gastroenterology52(4), 752–757 (1967).
   PubMed Web of Science ®Google Scholar
• Hofmann AF. Bile acids: trying to understand their chemistry and biology with the hope of helping patients. Hepatology49(5), 1403–1418 (2009).
   PubMed Web of Science ®Google Scholar
• Westergaard H. Bile acid malabsorption. Curr. Treat. Options Gastroenterol.10(1), 28–33 (2007).
   PubMedGoogle Scholar
• Fromm H, Hofmann AF. Breath test for altered bile-acid metabolism. Lancet2(7725), 621–625 (1971).
   PubMed Web of Science ®Google Scholar
• Boyd GS, Merrick MV, Monks R, Thomas IL. Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. J. Nucl. Med.22(8), 720–725 (1981).
   PubMed Web of Science ®Google Scholar
• Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br. Med. J. (Clin. Res. Ed.)290(6469), 665–668 (1985).
   PubMed Web of Science ®Google Scholar
• Sciarretta G, Fagioli G, Furno A et al. 75SeHCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut28(8), 970–975 (1987).
   PubMed Web of Science ®Google Scholar
• Ford GA, Preece JD, Davies IH, Wilkinson SP. Use of the SeHCAT test in the investigation of diarrhoea. Postgrad. Med. J.68(798), 272–276 (1992).
   PubMed Web of Science ®Google Scholar
• Williams AJK, Merrick MV, Eastwood MA. Idiopathic bile acid malabsorption – a review of clinical presentation, diagnosis, and response to treatment. Gut32, 1004–1006 (1991).
   PubMed Web of Science ®Google Scholar
• Nyhlin H, Merrick MV, Eastwood MA. Bile acid malabsorption in Crohn’s disease and indications for its assessment using SeHCAT. Gut35, 90–93 (1994).
   PubMed Web of Science ®Google Scholar
• Smith MJ, Cherian P, Raju GS, Dawson BF, Mahon S, Bardhan KD. Bile acid malabsorption in persistent diarrhoea. J. R. Coll. Physicians (Lond.)34, 448–451 (2000).
   PubMedGoogle Scholar
• Wildt S, Rasmussen SN, Madsen JL, Rumessen JJ. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test. Scand. J. Gastroenterol.38, 826–830 (2003).
   PubMed Web of Science ®Google Scholar
• Thaysen EH, Pedersen L. Diarrhoea associated with idiopathic bile acid malabsorption. Fact or fantasy? Dan. Med. Bull.20(6), 174–177 (1973).
   PubMed Web of Science ®Google Scholar
• Thaysen EH, Pedersen L. Idiopathic bile acid catharsis. Gut17(12), 965–970 (1976).
   PubMed Web of Science ®Google Scholar
• Fromm H, Malavolti M. Bile acid induced diarrhoea. Clin. Gastroenterol.15, 567–582 (1986).
   PubMedGoogle Scholar
• Wedlake L, A’Hern R, Thomas K, Walters JRF, Andreyev HJN. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol. Ther.30, 707–717 (2009).
   PubMed Web of Science ®Google Scholar
• Ford AC. Applicability of the reported prevalence of bile salt malabsorption in irritable bowel. Aliment Pharmacol. Ther.31(1), 161–162 (2010).
   PubMed Web of Science ®Google Scholar
• Khalid U, Lalji A, Stafferton R, Andreyev J. Bile acid malabsorption: a forgotten diagnosis? Clin. Medicine10(2), 124–126 (2010).
   PubMed Web of Science ®Google Scholar
• Brydon WG, Nyhlin H, Eastwood MA, Merrick MV. Serum 7 α-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur. J. Gastroenterol. Hepatol.8(2), 117–123 (1996).
   PubMed Web of Science ®Google Scholar
• Sauter GH, Munzing W, von Rilter C, Paumgartner G. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7α-hydroxy-4-cholesten-3-one in serum. Dig. Dis. Sci.44(1), 14–19 (1999).
   PubMed Web of Science ®Google Scholar
• Camilleri M, Nadeau A, Tremaine WJ et al. Measurement of serum 7 α-hydroxy-4-cholesten-3-one (or 7 αC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol. Motil.21(7), 734–e43 (2009).
   PubMed Web of Science ®Google Scholar
• Fernandez-Banares F, Esteve M, Salas A et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am. J. Gastroenterol.102(11), 2520–2528 (2007).
   PubMed Web of Science ®Google Scholar
• Fan X, Sellin JH. Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea. Aliment. Pharmacol. Ther.29(10), 1069–1077 (2009).
   PubMed Web of Science ®Google Scholar
• Spiller RC, Thompson WG. Bowel disorders. Am. J. Gastroenterol.105(4), 775–785 (2010).
   PubMed Web of Science ®Google Scholar
• Thomas PD, Forbes A, Green J et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut52(Suppl. 5), v1–v15 (2003).
   Google Scholar
• Williams JG, Roberts SE, Ali MF et al. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut56(Suppl. 1), 1–113 (2007).
   PubMed Web of Science ®Google Scholar
• Leeds JS, Hopper AD, Sanders DS. Coeliac disease. Br. Med. Bull.88(1), 157–170 (2008).
   PubMed Web of Science ®Google Scholar
• Richey R, Howdle P, Shaw E, Stokes T. Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance. BMJ338, b1684 (2009).
   Google Scholar
• Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology102(1), 330–354 (1992).
   PubMed Web of Science ®Google Scholar
• Hiatt JG, Shamsie SG, Schectman G. Discontinuation rates of cholesterol-lowering medications: implications for primary care. Am. J. Manag. Care5(4), 437–444 (1999).
   PubMed Web of Science ®Google Scholar
• Rossel P, Sortsoe JH, Qvist P, Arveschoug A. Prognosis of adult-onset idiopathic bile acid malabsorption. Scand. J. Gastroenterol.34(6), 587–590 (1999).
   PubMed Web of Science ®Google Scholar
• Wedlake L, Thomas K, Lalji A, Anagnostopoulos C, Andreyev HJN. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire. Clin. Therap.31(11), 2549–2558 (2009).
   PubMed Web of Science ®Google Scholar
• Walters JRF, Pattni SS. Managing bile acid diarrhoea. Therap. Adv. Gastroenterol. (2010) (In press).
   PubMedGoogle Scholar
• Sollid LM, Khosla C. Future therapeutic options for celiac disease. Nat. Clin. Pract. Gastroenterol. Hepatol.2(3), 140–147 (2005).
   PubMedGoogle Scholar
• Bajor A, Kilander A, Galman C, Rudling M, Ung KA. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis. Aliment. Pharmacol. Ther.24(11–12), 1643–1649 (2006).
   PubMed Web of Science ®Google Scholar
• Ung KA, Gillberg R, Kilander A, Abrahamsson H. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut46(2), 170–175 (2000).
   PubMed Web of Science ®Google Scholar
• van Tilburg AJ, de Rooij FW, van den Berg JW, van Blankenstein M. Primary bile acid diarrhoea without an ileal carrier defect: quantification of active bile acid transport across the ileal brush border membrane. Gut32(5), 500–503 (1991).
   PubMed Web of Science ®Google Scholar
• Bajor A, Kilander A, Fae A et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur. J. Gastroenterol. Hepatol.18(4), 397–403 (2006).
   PubMed Web of Science ®Google Scholar
• van Tilburg AJ, de Rooij FW, van den Berg JW, van Blankenstein M. Primary bile acid malabsorption: a pathophysiologic and clinical entity? Scand. J. Gastroenterol. Suppl.194, 66–70 (1992).
   PubMedGoogle Scholar
• Oelkers P, Kirby LC, Heubi JE, Dawson PA. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J. Clin. Invest.99, 1880–1887 (1997).
   PubMed Web of Science ®Google Scholar
• Montagnani M, Love MW, Rössel P, Dawson PA, Qvist P. Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption. Scand J. Gastroenterol.36, 1077–1080 (2001).
   PubMed Web of Science ®Google Scholar
• Montagnani M, Abrahamsson A, Galman C et al. Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption. World J. Gastroenterol.12(47), 7710–7714 (2006).
   PubMed Web of Science ®Google Scholar
• Balesaria S, Pell RJ, Abbott LJ et al. Exploring possible mechanisms for primary bile acid malabsorption: evidence for different regulation of ileal bile acid transporter transcripts in chronic diarrhoea. Eur. J. Gastroenterol. Hepatol.20(5), 413–422 (2008).
   PubMed Web of Science ®Google Scholar
• Bajor A, Ung KA, Ohman L et al. Indirect evidence for increased mechanosensitivity of jejunal secretomotor neurones in patients with idiopathic bile acid malabsorption. Acta Physiol. (Oxf.)197, 129–137 (2009).
   PubMed Web of Science ®Google Scholar
• Walters JRF, Tasleem AM, Omer OS, Brydon WG, Dew T, Le Roux CW. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin. Gastro. Hepatol.7, 1189–1194 (2009).
   PubMed Web of Science ®Google Scholar
• Inagaki T, Choi M, Moschetta A et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell. Metab.2(4), 217–225 (2005).
   PubMed Web of Science ®Google Scholar
• Inagaki T, Moschetta A, Lee YK et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl Acad. Sci. USA103(10), 3920–3925 (2006).
   PubMed Web of Science ®Google Scholar
• Lundasen T, Galman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J. Intern. Med.260(6), 530–536 (2006).
   PubMed Web of Science ®Google Scholar
• Odunsi-Shiyanbade ST, Camilleri M, McKinzie S et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin. Gastroenterol. Hepatol.8(2), 159–165 (2010).
   PubMed Web of Science ®Google Scholar
• Tomiyama K, Maeda R, Urakawa I et al. Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc. Natl Acad. Sci. USA107(4), 1666–1671 (2010).
   PubMed Web of Science ®Google Scholar
• Hofmann AF. Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last. Expert Rev.Gastroenterol. Hepatol.3(5), 461–464 (2009).
   PubMedGoogle Scholar